Kaiser Permanente Ventures, the corporate venturing unit of the US's largest health care system, has joined the consortium investing $45m in the series B round for Agile Therapeutics, which is making a contraceptive patch for women.
Kaiser Permanente Ventures, the corporate venturing unit of the US’s largest health care system, has joined the consortium investing $45m in the series B round for Agile Therapeutics, which is making a contraceptive patch for women.
Venture capital firms Investor Growth Capital and Care Capital co-led the B round, which included peers ProQuest Investments and Novitas Capital.
